ipl-logo

Cheap Pharma Case Summary

735 Words3 Pages

1. Immediate Issue(s) or Problem(s):
Immediate problem
-Cheap Pharma Inc., a pharmaceutical company specializing in generic drugs, had been suffering low sales in the past months because of fierce competition from other generic drug brands.
Decision
-Of course to be able to get back high sales in the medicines that the company is offering, we must formulate or innovate new products or buy a shares to the competitors to use.
Time frame
-As soon as possible.
2. Basic Issue(s) or Associated Issue(s):
-The shareholders of the Cheap Pharma sued Mr. De Guzman and the other two directors demanding that they render an accounting and return whatever profits they made from the Green Med transaction to Cheap Pharma.
3. Issue(s) Analysis or Information …show more content…

-Mr. De Guzman and the two other directors who processed the transactions convinced Dr. Gonzales to sell the shares to them instead.
-The shareholders of the Cheap Pharma sued Mr. De Guzman and the other two directors demanding that they render an accounting and return whatever profits they made from the Green Med transaction to Cheap Pharma.
Long term issue
-Cheap Pharma Inc., a pharmaceutical company specializing in generic drugs, had been suffering low sales in the past months because of fierce competition from other generic drug brands.
4. Alternative Solutions or Options:
A. Formulate their own Lagundi medicine.
-Innovation is one of the best solution for you to be able to stay in the market. To try a new product or to innovate an existing product is a chance. However, trying to innovate is a trial and error process. For you to formulate a medicine is to invest labor and equipment. But at the end of the day, if you successfully discovered or invented a new medicine, and if the market see that your product is a need, for sure your business will stay on the right

Show More
Related

  • Walgreen's Breach Case

    1843 Words  | 8 Pages

    In court, Sara Creek had to justify the breach and hoped to pay damages, but Walgreen’s desired an injunction. Before comparing damages to an injunction in this specific case, it is helpful to mention the general differences between the two. One advantage of awarding an injunction (specific performance) is that it is on the parties to negotiate damages that benefit both sides. If the transaction costs are low, it could be more efficient to award an injunction. An injunction effectively takes the two parties to the market, which will determine the price of breaching more accurately than the government.

    Read More

  • Case Study: Cornerstone V. Texas

    331 Words  | 2 Pages

    FACTS: Cornerstone is a Texas company that owns hospitals and was in the market to grow its business. Some of the Cornerstone executives, the Respondent, came across an investment and used Cornerstone funds to expand and buy new companies without consulting Cornerstone’s board. These executives later resigned and continued to make business under the new formed companies. Cornerstone filed a suit stating that Respondent’s actions were against their fiduciary duty. One of the investments was made with Nautic Partners whose firm is in Rhode Island.

    Read More

  • Walgreens Case Analysis

    300 Words  | 2 Pages

    Practitioners collaborate with local physicians who are available for consultation at all times patients are being treated. This writer has been employed with the Healthcare Clinic at Walgreens since 2008. Majority of the information presented in this paper are from this writer’s first hand experience while working for the company. For academic purposes, this paper explores the challenges and opportunities dealt by the company from 2008 until the present. Investigate the problem and collect evidence to support the fact that the problem exists.

    Read More

  • Epipen Persuasive Essay

    342 Words  | 2 Pages

    This action taken by the government into the investigation of the monopoly of EpiPens has uncovered that Mylan has been misclassifying the EpiPens for years. Mylan was supposed to classify EpiPen as a single source (meaning brand name drug) which would require them to provide Medicaid rebate of 23.1% of the cost and inflation rebate, but instead they classified it as a generic version of a drug which only requires 13% Medicaid rebate of the cost and no inflation rebate (Mole). This may cause the government to give Mylan penalties, and it may cause the government to make claims on sales. The government is penalizing and criticizing Mylan for using the system incorrectly, and the government is supporting generic versions of EpiPens and different brands to come to the United States to stop the monopoly and increase competition. Although some patent laws created by the government have created an epinephrine auto-injector monopoly in the United States, the government is working now to eliminate this monopoly and penalize Mylan for using it to its

    Read More

  • Richard Scrushy: The Healthsouth Fraud Case

    699 Words  | 3 Pages

    Most people in the state of Alabama are aware of the HealthSouth scandal due to former Alabama Governor Don Siegelman being convicted of crimes of bribery, and honest services fraud along with former CEO Richard Scrushy. The HealthSouth fraud case was also one of the first fraud cases tried under the Sarbanes Oxley Act of 2002. HealthSouth officers were cooking-books and shell games trying to mask the fraud that was occurring by acquiring companies, overstating cash balances, falsifying financial statements earnings releases as well as annual reports. The fraud also involved booking the accounts receivable amounts as income instead of collectable income, fictitious fixed assets such as office equipment, recording the sale of shares in another

    Read More

  • Inquirie Granting The Medicines Case Analysis

    447 Words  | 2 Pages

    Harpo C. Chord (п) was offered to play the piano during dinner at Tres Trendi, an upscale restaurant in the theater district. (∆). Even though п did not have this in mind for his career opportunity, due to financial situation being depleted, accepted the K. ∆ was a restaurant in the theater district, and many participants were influential in the arts, п saw this as an opportunity and accepted the offer on January 15th, and entered a K with ∆. The K had promised that he would play piano during dinner from 8pm-midnight every night for the month. П’s performance would begin on February 1st, and would be paid “the going rate” for his piano playing.

    Read More

  • Martin Shkreli Fraud Case Study

    319 Words  | 2 Pages

    Prospective jurors believe that Martin Shkreli is "the face of corporate greed in America." Shkreli, best known for raising the price of life-saving pharmaceuticals, is charged in links with securities fraud. Prosecutors say he manipulated investors in one company and then overcharged his other company to pay them back. Shkreli’s defense attorneys, however, arrest that he paid them back.

    Read More

  • Novelty Now Case Summary

    1208 Words  | 5 Pages

    Their poor values have caused extensive damage to Donald, the plaintiff. Finally the last key element in the process of ethical decision-making is How. The defendants needed to ask themselves why they did not let the public know the new chemical was not FDA approved. The three men and Novelty Now did not ask themselves what would happen if everybody followed their guidelines. If they had asked themselves these questions they would have realized they were making unethical decisions.

    Read More

  • Novo Nordisk Case Study

    125 Words  | 1 Pages

    Novo Nordisk prides itself in keeping their Triple Bottom Line and that is something I truly appreciate because it takes the ethical implications presented in my introductory courses and demonstrates that it is possible to be successful and benefit the surrounding social and economic environment at the same time. Thus, if I am chosen for this program I will bring my unique leadership style, intellectual acuity, and professionalism to work successfully with a team and aid the various departments in any projects available. I would be honored to join Novo Nordisk this summer and learn an immense amount from talented professionals and fellow colleagues alike. Overall, I am immensely grateful for your consideration and look forward to the opportunity

    Read More

  • Case Study: Pruitthealth Pharmacy

    238 Words  | 1 Pages

    PruittHealth Pharmacy is entering into to a relationship with Kaiser Permanente whereas PH will provide drugs, supplies and pumps to be administer to KP’s chemo patients, by KP clinical staff within the KP Chemo department. We are very excited about this opportunity as we believe that not only will this relationship generate revenue, it may also lead to other financial opportunities. That being said, this is new to us and we want to insure that not only is our pricing is robust, but we need a contract/LOA in which we can operate feasibly, protect our interests, and provide an easy out of the relationship does not work for us. Attached is an LOA to begin the relationship, while we work through a contract to solidify the arrangement. Can you

    Read More

  • Organizational Development Intervention Project Paper

    551 Words  | 3 Pages

    The nature of these problems is consumer protection and interest. These problems are very severe. If not addressed than it could lead to the destruction of the corporation. These problems are not specific to this corporation, all organizations in this industry face these issues. The root cause of these problems stem from advancing technology.

    Read More

  • Arguments Against Big Pharma

    1087 Words  | 5 Pages

    Every citizen in the United States has individual rights protected by the Constitution. This protection also includes businesses that have gone through the legal process to become a legal entity ; more commonly known as becoming a corporation. Many times these individual rights, protected by the Constitution, conflict with the common good and as history shows, the courts consistently side with the common good when faced with a case that pits these two against each other. Big Pharma are corporations exercising their individual rights to market, and sell their product to consumers. In the process, the common good is suffering.

    Read More

  • Taking A Look At Ego Pharmaceuticals

    1656 Words  | 7 Pages

    In this essay, two communication attempts will be analysed and evaluated based on established communication models. I will first introduce you to the organisation I work with, Ego Pharmaceuticals, and also give you a brief breakdown of communication theory. Next, I will analyse two attempts at communication within the organisation. As a Demand Analyst at Ego Pharmaceuticals, my job primarily involves developing statistical models, and analysing data to determine trends and relationships. However a significant portion of my time now involves regular communication with a large number overseas staff in both Asia and the Middle East, relating to forecasting processes and models.

    Read More

  • The Importance Of Due Diligence In Health Care

    654 Words  | 3 Pages

    Failure to understand and address these risks can quickly sour an otherwise attractive deal. Any M&A transaction brings with it a set of common pitfalls; experienced deal lawyers have developed ways to spot and avoid these hazards. However, to meet the additional challenges of health care transactions and ultimately facilitate a successful deal, targeted due diligence is

    Read More

  • Porter's Five Forces Analysis Pharmaceutical Industry

    720 Words  | 3 Pages

    Many new companies to enter the market without burden of costly tasks such as research and development, clinical trials and manufacturing of drugs. Moreover, patent expiry is one of the reasons which is offering opportunities for lower cost generic manufacturer in terms of greater market access. Additionally, the government has increased their focus on healthcare cost cutting. It is creating pressure on the authority to allow early introduction of low-cost drugs in the

    Read More

More about Cheap Pharma Case Summary

Open Document